Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Clinical Practice|June 9, 2021
Non-HDL cholesterol is an independent predictor of long-term cardiovascular events in patients with dyslipidemia after renal transplantationUmut Karabulut, Ülkem Çakır
Angiology|September 25, 2021
Effect of Sacubitril/Valsartan Combined with Dapagliflozin on Long-Term Cardiac Mortality in Heart Failure with Reduced Ejection FractionUmut Karabulut, Kudret Keskin, Dilay Karabulut, et al.
Acta Cardiologica|September 28, 2023
Predictive value of triglyceride/glucose index for cardiac outcomes in non-diabetic renal transplant recipientsDilay Karabulut, Umut Karabulut, Muhsin Kalyoncuoğlu, et al.
Annals of Vascular Surgery|August 16, 2016
Endovascular Treatment of Acute Aortic Occlusion with Critical Limb Ischemia using an AngioJet DeviceMete Gursoy, Egemen Duygu, Umut Karabulut, et al.
Anatolian Journal of Cardiology|April 18, 2022
Periprocedural, Short-Term, and Long-Term Outcomes of Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A 20-Year Single-Center ExperienceUmut Karabulut, Yeşim Yılmaz Can, Egemen Duygu, et al.
Journal of Infection in Developing Countries|January 13, 2026
Predictive value of blood gas parameters and hematologic indices on survival in critically ill sepsis patientsNazmi Toprak, Bekir Kaya, Jehat Kiliç, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|December 7, 2019
The association between CHA2DS2-VASc score and erectile dysfunction: a cross-sectional studyDilay Karabulut, Umut Karabulut, Fatma Nihan Cağlar, et al.
Journal of Clinical Medicine|December 11, 2025
Comparative Long-Term Cardiovascular Outcomes of Empagliflozin and Dapagliflozin in Heart Failure Patients After Coronary Revascularization: A Retrospective Cohort StudyIlhan Ozgol, Cennet Yildiz, Ece Yigit Gencer, et al.
ESC Heart Failure|September 28, 2024
Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: The RED-HEART studyUmut Kocabas, Isil Ergin, Veysel Yavuz, et al.
Clinical Cardiology|January 28, 2025
Incidence and Predictors of Clinical Outcomes in Real-Life Patients With Atrial Fibrillation Treated With Oral Factor Xa Inhibitors: The Follow-Up Results of the ANATOLIA-AF StudyUmut Kocabaş, Isil Ergin, Sadi Can Sönmez, et al.
Pageof 2